Literature DB >> 12972604

Comprehensive structure-function analysis of the core domain of human telomerase RNA.

Hinh Ly1, Elizabeth H Blackburn, Tristram G Parslow.   

Abstract

Telomerase is a cellular reverse transcriptase that uses part of its integral RNA (called TER) as the template to synthesize telomeric DNA repeats. Vertebrate TERs are thought to share a conserved, highly structured core domain that includes the templating sequence and a pseudoknot, but not all features of the predicted core structure have been verified directly or shown to affect telomerase enzymatic activity. Here, we report a systematic mutational analysis of the core domain (residues 1 to 210) of human telomerase RNA (hTER). Our data confirm that optimal hTER activity requires the integrity of four short helices (P2a.1, P2a, P2b, and P3) which create the proposed pseudoknot and that features of both the primary sequence and secondary structure in P2b and P3 contribute to optimal function. At least part of the long-range P1 pairing is also required, despite the lack of a known P1 counterpart in rodent TERs. Among the predicted single-stranded regions, we found that J2b/3, portions of J2a/3, and residues in and around the template make sequence-specific contributions to telomerase function. Additionally, we provide evidence that naturally occurring hTER sequence polymorphisms found in some patients with aplastic anemia can inhibit telomerase activity by disrupting critical structures within the hTER core domain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972604      PMCID: PMC193926          DOI: 10.1128/MCB.23.19.6849-6856.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

1.  Analysis of the structure of human telomerase RNA in vivo.

Authors:  Mária Antal; Eva Boros; Ferenc Solymosy; Tamás Kiss
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

Review 2.  Switching and signaling at the telomere.

Authors:  E H Blackburn
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

3.  A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation.

Authors:  M M Kim; M A Rivera; I L Botchkina; R Shalaby; A D Thor; E H Blackburn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

4.  A molecular switch underlies a human telomerase disease.

Authors:  Luis R Comolli; Ivan Smirnov; Lifeng Xu; Elizabeth H Blackburn; Thomas L James
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

5.  Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions.

Authors:  F Bachand; C Autexier
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  Identification of functional domains and dominant negative mutations in vertebrate telomerase RNA using an in vivo reconstitution system.

Authors:  L Martin-Rivera; M A Blasco
Journal:  J Biol Chem       Date:  2000-10-30       Impact factor: 5.157

7.  A critical stem-loop structure in the CR4-CR5 domain of mammalian telomerase RNA.

Authors:  Jiunn-Liang Chen; Kay Keyer Opperman; Carol W Greider
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

8.  Human telomerase RNA-protein interactions.

Authors:  F Bachand; I Triki; C Autexier
Journal:  Nucleic Acids Res       Date:  2001-08-15       Impact factor: 16.971

9.  Functional multimerization of the human telomerase reverse transcriptase.

Authors:  T L Beattie; W Zhou; M O Robinson; L Harrington
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

10.  Association between aplastic anaemia and mutations in telomerase RNA.

Authors:  Tom Vulliamy; Anna Marrone; Inderjeet Dokal; Philip J Mason
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

View more
  37 in total

Review 1.  Telomeres and telomerase.

Authors:  Simon R W L Chan; Elizabeth H Blackburn
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-01-29       Impact factor: 6.237

2.  Structurally conserved five nucleotide bulge determines the overall topology of the core domain of human telomerase RNA.

Authors:  Qi Zhang; Nak-Kyoon Kim; Robert D Peterson; Zhonghua Wang; Juli Feigon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-21       Impact factor: 11.205

3.  Functional analysis of the pseudoknot structure in human telomerase RNA.

Authors:  Jiunn-Liang Chen; Carol W Greider
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-22       Impact factor: 11.205

4.  RNA connectivity requirements between conserved elements in the core of the yeast telomerase RNP.

Authors:  Melissa A Mefford; Qundeel Rafiq; David C Zappulla
Journal:  EMBO J       Date:  2013-10-15       Impact factor: 11.598

5.  Architecture of human telomerase RNA.

Authors:  Qi Zhang; Nak-Kyoon Kim; Juli Feigon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

Review 6.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

7.  Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies.

Authors:  M A Trudeau; J M Y Wong
Journal:  Curr Pharmacogenomics Person Med       Date:  2010-03-01

Review 8.  New perspectives on telomerase RNA structure and function.

Authors:  Cherie Musgrove; Linnea I Jansson; Michael D Stone
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-11-09       Impact factor: 9.957

9.  Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer.

Authors:  Tara J Moriarty; Delphine T Marie-Egyptienne; Chantal Autexier
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  Solution structure and dynamics of the wild-type pseudoknot of human telomerase RNA.

Authors:  Nak-Kyoon Kim; Qi Zhang; Jing Zhou; Carla A Theimer; Robert D Peterson; Juli Feigon
Journal:  J Mol Biol       Date:  2008-10-11       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.